Discussions à la une

"THE BOOK OF VVM: Yesterday-today-and-tomorrow" is now available for free download

The story of a time and temperature indicator (vaccine vial monitor) that has dramatically changed the course of vaccine management practices as well as shaped the future of cold chain, THE BOOK OF VVM: YESTERDAY-TODAY-and-TOMORROW is now available for free download in ePUB3 and PDF formats. http://kartoglu.ch/vvm We may ask ourselves where humanity might be without some of the greatest inventions that have come to pass. Great ideas have continuously changed the path of human civilization over time with vaccination being widely considered one of the greatest medical achievements of modern civilization. Many commonplace and preventable childhood diseases are now increasingly rare because of vaccines. The concerted human effort to bring the vaccines to the ones who need them at the right time is remarkable. Just one example of the dedication and self-sacrifice involved was the 1925 ‘Serum Run’ between the settlements of Nenana and Nome in Alaska also known as the Great Race of Mercy. This involved a famously grueling winter expedition across the frozen Alaskan interior using dog-sled relays to take diphtheria antitoxin to the beleaguered township of Nome where an outbreak of diphtheria was threatening around 10,000 local Alaskan natives who had no natural immunity to this lethal disease. The epic journey took 20 mushers and about 150 sled dogs just five and a half days to cover the 1,085 km route. This display of bravery and determination was how the small town of Nome and the communities surrounding it were saved from an incipient epidemic. Balto, the lead sled dog on the final leg into Nome, became the most famous canine celebrity of the era. Balto’s statue became a popular tourist attraction both in New York City’s Central Park and downtown Anchorage in Alaska. The vaccine vial monitor (VVM) is one of the most important inventions of the last century; one that has dramatically changed vaccine management practices and continues to shape the cold chain. In 1996, when VVMs started to get to countries with the oral polio vaccine (OPV), I was the health officer for the UNICEF Central Asian Republics and Kazakhstan Area Office. I remember one particularly cold night going to the airport in Almaty at 03.00 am to receive the very first shipment of OPV with VVMs. For years, I was a humble VVM user and advocate in the field. Things started to change when I was hired by the WHO Headquarters ‘Access to Technologies’ team in 2001 and VVM became one of my prime responsibilities. That was at a time when vaccine manufacturers were dragging their feet about incorporating VVM onto vaccines other than OPV. My brief was to overcome this resistance from the manufacturers, an objective that formed the basis for my plans for the historic 2002 VVM technical consultation meeting. In 2007, I immensely enjoyed organizing the event to celebrate the 10th year anniversary of VVM introduction. Visiting Niger, Indonesia, and Vietnam for the shooting of the “Five Senses” video is full of cherished moments. Towards my retirement in August 2018, I conceived the idea of writing this book. I was one of the few people who had witnessed the decades-long programme of VVM development from its birth to its maturity. I had worked with sweat and tears to get VVMs onto all vaccines as well as tirelessly helping vaccine managers and health staff to excel in using the VVMs to their utmost potential. Today, it is a great pleasure to see one of my e-VVM based vaccine management course graduates (2015), Junaidu Adamu Barde from Nigeria, working for the Clinton Health Access Initiative, using the course learning materials to duplicate efforts in his country. I worked on this book from September 2018 to August 2019. I went through every single published and unpublished work on VVMs, watched all available videos about VVMs and the early contending products, talked to key people, some face to face, others over the phone. I visited the U.S., Albania, Burkina Faso, and Sierra Leone. Unfortunately, there were some people I just could not reach despite all my efforts with email and phone messages. And, although I considered myself highly knowledgeable about VVM, I was simply amazed at the volume of new information I discovered and the knowledge I gained. I had originally wanted this book to be a concise, structured, globally-relevant manual that provided comprehensive information on a wide scope of issues; in other words, an ‘A-Z of VVM’. In the event, it turned out to be more voluminous than I thought. I did not want to restrict myself when there are so many clever, dedicated and selfless individuals that have made this near-miraculous innovation a reality and in doing so contributed to saving, literally, the lives of millions. So, I am happy that it became a celebration of all the efforts of individuals, organizations, agencies, donors, and manufacturers involved in the development, scaling, applying, advocating for, enforcing, helping health workers to excel in their practice, and using it. As with my previous books, I have again licensed this work under the Creative Commons (CC) Attribution-NonCommercial-ShareAlike 4.0 International License (CC BY-NC-SA 4.0). The book can be reproduced, remixed, tweaked or built upon non-commercially. I am grateful to Temptime Corporation, and especially to Renaat Van den Hooff and Ted Prusik for sponsoring the creation of this book. I thank Emily Moore for the VVM literature list she put together, it eased my search enormously. I also thank all the individuals I have interviewed for their time and everything they have shared with me. I am thankful to all my colleagues who sent me photographs, and documents. Many thanks to Kadir Abbas for making again an excellent job on the cover and page design, print, and ePUB3 conversion. Gencer Yurttas deserves a special thank you for his immaculate VVM photography. I deeply appreciate Alan Kennedy for his editing work, and Umran and Gokhan Akaalp's help in developing the book’s website. I am grateful to my wife Nellie and daughter Deniz Nala who supported me with love. Deniz Nala was already helping me at the age of 14 measuring VVMs with a spectrodensitometer and entering data into an Excel sheet to calculate optical density differences during a VVM based vaccine management eLearning course. I never imagined that for something only 0.38 cm2 in size that I could write a book of 424 pages. This ‘little big thing’, now reinventing itself with the incorporation of a peak threshold indicator as well as entering the digitized supply chain with the integration of 2D barcodes, never ceases to amaze me. For download please visit http://kartoglu.ch/vvm The book is available both in interactive PDF (32.9 MB) and ePUB3 (24.4 MB) versions. 424 pages...  

Updated Gavi CCEOP Technology Guide

Hi all, Gavi, the Vaccine Alliancce has updated the Cold Chain Equipment ‘Technology Guide’, to support the appropriate selection of modern, efficient and reliable technologies. We wanted to let you know the updated CCEOP Technology Guide is available here (and attached) and will permanently be hosted on this page of the Gavi website.    The Technology Guide, which was complied through inputs from Alliance partners and technical asistance providers, provides an overview of equipment that is eligble for support through Gavi's Cold Chain Equipment Optimisation Platform (CCEOP). It also provides guidance on identifying the most appropriate equipment choices for each health facility to help ensure more facilities have adequate cold chain capacity from higher performing equipment that stays functional for longer periods of time. Equipment included in the Guide is PQS certified and meets additional platform eligibility requirements. The Guide is intended in particular for use in identifying CCE needs and solutions for health facilities and at lower levels of the cold chain.    The Technology Guide is also available as part of the TechNet ‘Cold Chain Equipment Management - Technical Resources’ page here. The Technology Guide will be updated twice a year. Please contact Karuna Luthra (Gavi Market Shaping) with any questions. 

Keeping the promise

Dear viewers, we wish to share the attached with the techNet community          This year on 14th November 2019, we celebrated “EuVac award ceremony” in our college to felicitate the parents for getting their children graduated timely with primary vaccination before first birth day and booster before 2nd birthday. On 14th It was decided to felicitate the parents throughout the year on the day of vaccination with DPT & OPV 1st booster and MR 2nd dose. This is adding jubilance both to the service provider and the beneficiaries though it incurs a little extra to the management. Vaccination service is free as the essential vaccines of National Immunization Schedule is supplied free on a regular basis by the district health and family welfare services and administered free. Regards KVG team  

Polio resurgence

Last Friday (Dec 6), The Star reported the country’s Health Ministry confirming that a three-month-old boy from Tuaran, Sabah, has been infected with vaccine-derived poliovirus type 1 (VDPV1) after being admitted into a hospital’s intensive care unit. The Star quoted health director-general Dr Noor Hisham Abdullah who said on Sunday (Dec 8): “The patient is currently undergoing treatment in an isolation ward and is in stable condition but needs respiratory support.” He added that the poliovirus is classified as a circulating vaccine-derived poliovirus type 1 (VDPV1), which originates from a poliovirus that has been weakened by the orally-administered polio vaccine. The Star reported that Dr Hisham said the weakened virus excretes from the body through faeces. However, in unsanitary environments, the virus can infect others who have not been immunised against polio and will “thus spread in communities whose polio immunisation rates are less than 95 per cent”. He warned that if the disease is left uncontrolled, it can genetically mutate until it once again becomes an active virus. In an article on Monday (Dec 9), The Associated Press (AP) quoted Dr Hisham as saying that vaccination will be stepped up after an investigation in the infant’s home village showed that 25 out of 204 children, aged between two months and 15 years, were not vaccinated against polio.
Link: https://www.businessinsider.my/malaysias-first-polio-case-in-27-years-is-a-child-who-wasnt-vaccinated-here-are-3-things-to-know-about-the-incurable-virus/

05 days International training programme on “Logistics Management of Vaccines with special focus on Strengthening Cold chain ” during April 20-24,2020 at The IIHMR University, Jaipur, India .

Respected Sir/Madam  
Greetings from IIHMR UNIVERSITY, JAIPUR , INDIA I take immense pleasure to share with you that School of Pharmaceutical Management; The IIHMR University is organizing a 05 days International training programme on “Logistics Management of Vaccines with special focus on Strengthening Cold chain ” during April 20-24,2020 at The IIHMR University, Jaipur, India. The program is designed primarily with a focus to assist the countries/national health system programs to address the challenges in vaccine management thus ensuring access to quality vaccines in the immunization program. The program contents are as below PROGRAM CONTENTS: -
Introduction to immunization basics and Universal Immunization Program (UIP) Procurement of vaccines Cold chain management Key elements of cold chain system Cold chain Equipment’s and their maintenance Monitoring the cold chain temperature Vaccines Management Demand estimation Indenting Stock Management Storage & Distribution Supportive supervision Reporting/Documentation & MIS AEFI and Immunization Waste Management eVIN- Effectively managing vaccine logistics Social mobilization, advocacy and communication for EPI Field visit to cold chain point  Hands on training on temperature monitoring devices Link for brochure https://www.iihmr.edu.in/files/training/brochure/170/logistics-management-of-vaccines.pdf PROGRAMME FEE Foreign Nationals: USD 700 per participant plus 18% GST Indian Nationals: Rs 37,500 per participant plus 18% GST The fees cover tuition fees, training material, stay in air-conditioning room (twin-sharing basis), breakfast, lunch, dinner, tea/coffee during the program and pick-up and drop from Jaipur airport/railway station/bus stand. Welcome dinner and short-trip to historical and cultural importance places in Jaipur would be offered by the University in honor of the participants. Participants would be encouraged to use library facilities. Around the clock internet facility (Wi-Fi) is available for the participants. The travel tickets from the country of origin to Jaipur and vice versa are to be borne by the participant/sponsoring agency.  DISCOUNTS ON THE FEE
Early Bird Discount: Nominations received with payments on/before 4-weeks (23rd March 2020) will be entitled to an early bird discount of 10%. Group Discount: Any organization sponsoring four or more participants to the program will be entitled for a discount of 20% on the total fee payable provided that at least four participants attend the program. Maximum Discount: Organization can avail themselves of both the discount subject to maximum discount of 20%. I am sure that you will find it useful for the organization/national health system program. I would be grateful, if you could participate/nominate interested candidates in the training program. You may forward to concerned department also Kindly send the filled and scanned nomination form (attached) to the program coordinator at saurabh@iihmr.edu.in    Looking forward for your kind cooperation and support to make the program success. A word of response would be appreciated. Regards   Dr.Saurabh kumar Banerjee  M.Pharm, Ph.D., MBA Associate  Professor and Program Coordinator The IIHMR University, 1 Prabhu Dayal Marg, Near Sanganer Airport Jaipur (Pin-302029), Rajasthan, INDIA Office: +91 141 3924700, Ext: 789,  Fax: +91 141 3924738, Mobile - +91-8890398067 Email: saurabh@iihmr.edu.in

RFP for Project Management support for "Immunization Agenda 2030"

Ebru Ekeman Publié dans :
Wellcome Trust has issued the enclosed RFP to seek project management support to support the development of the new immunization vision and strategy for the next decade - "Immunization Agenda 2030 (IA2030)" The post will be based in Geneva, WHO HQ. The proposal shall be submitted by close of business Dec 9th, 2019 directly to Genevieve Hughes at Wellcome (G.Hughes@wellcome.ac.uk)

Looking for Health Supply Chain and logistics advocacy materials targeted to decision-makers

Dear TechNet members, With the purpose of promoting strong health supply chain systems, I am looking for recent advocacy materials targeted to senior leadership on the benefits of implementing good supply chain strategies and practices to fully serve the needs of public sector facilities and their population. Thanks so much for sharing materials, guidance tools and experience at country level. Best wishes. Dorothy

Efficiency of Influenza vaccine

What is the efficiency of Influenza vaccine?

Join us on Thursday! Webinar: Five proven strategies to improve immunization data use

Join us for a webinar: Five proven strategies to improve immunization data use (Findings from the Immunization Data: Evidence for Action Review) Date: Thursday, December 5, 2019 3:00 pm
Europe Time (Paris, GMT+01:00) The use of high-quality data is widely understood in the global health community to be a cornerstone of well-functioning health systems. However, despite continuous growth in the amount of health data available, the actual use of data in immunization program decision-making remains a challenge. Part of the challenge has been a limited understanding of what tools and approaches actually are effective in increasing the use of immunization data to support improvements in vaccine delivery and access. The Immunization Data: Evidence for Action (IDEA) Review was undertaken to identify the existing evidence on what works to improve the use of immunization data, and to synthesize that evidence into actionable steps that implementers, policymakers and funders can take to design better data use interventions.

During this webinar, the presenters from PATH will share the methodology used to identify and review 549 pieces of evidence and five proven strategies to improve data use that were uncovered. They also will discuss the evidence gap map that was developed and how the global immunization community can work together to increase the quality of evidence available on best practices for data use to help further the work started by the IDEA team.


Discussion panelists

Laurie Werner- Director of Program, Center of Digital and Data Excellence, PATH
Allison Osterman- Program Officer, Health Systems Innovation and Delivery, PATH

Save the date and please join us! Link to register: https://who-meeting.webex.com/who-meeting/onstage/g.php?MTID=ec0039a66d95132ed3f30c6988ade4314

Recommendations from SAGE Oct 2019 - published today- Data Use and Quality highlighted

WER with recommendations from SAGE Oct 2019 was published today (attached). Below I highlight two areas related to immunization data use and quality. Enjoy the reading, Carolina “[Immunization Agenda 20330] IA2030 envisions a world in which “everyone, everywhere, at every age, fully benefits from vaccines for good health and well-being”. To achieve this vision, a balance is struck between a disease-specific and a systems approach, with commitment to existing goals for eradication and elimination, new goals for the next decade and alignment as closely as possible with the GVAP review. The 7 strategic priorities of the IA2030 framework are: 1) immunization for primary health care and universal health coverage, 2) commitment and demand, 3) coverage and equity, 4) life-course and integration, 5) outbreaks and emergencies, 6) supply and sustainability and 7) research and innovation. These priorities will be achieved on the basis of 4 core principles: people-focused, country-owned, partnership-based and data-enabled” __________________________________ “SAGE endorsed the following recommendations: Embed monitoring of data quality into global, regional and national monitoring of the surveillance of immunization and [vaccine-preventable diseases] VPDs. Increase the capacity and capability of the workforce for ensuring data quality and use, starting at the level at which data are collected. Improve the accuracy of denominators. Enhance use of all available data for tailored action, including programme planning, management and decision-making. Adopt a data-driven continuous quality improvement approach as part of health system strengthening at all levels. Strengthen governance of the pilot-testing and use of new tools for collection and use of immunization and surveillance data. Improve data-sharing and knowledge management among areas and organizations for greater transparency and efficiency. WHO and UNICEF should strengthen global reporting and data monitoring through a periodic needs assessment and revision process. These recommendations should be added to the IA2030, and regions and countries should include multi-component interventions for improving data quality and use in their regional 2021–2030 strategies. These recommendations should also be integrated into the broader efforts of [Universal Health Coverage] UHC and [Primary Health Care] PHC.”

Intensified Mission Indradhanush [IMI 2.0] Participation by private sector

Dear viewers India is committed and consistently trying to improve and sustain vaccination coverage. Despite the best efforts; we have to go only a few more miles to achieve and sustain >90% from the current 87% vaccination coverage for which GoI launched Intensified Mission Indradhanush [IMI 2.0]. In addition to the universal reasons which the country is addressing, good performing districts have additional district specific problems too which can be easily and locally addressed by the district task force [DTF] with proactive involvement of stakeholders, specifically private sector through simple doable measures. The attached is shared with the stakeholders of Dakshinakannada district. We wish to share with the global viewers as some of the issues like quality of vaccination service with regard to mainly the potency of the vaccine are questionable in the private sector. Once vaccinated by a private service provider, the babies permanently loose the opportunity of getting vaccines with known potency. For example, as of now, child has only one opportunity in its life time to receive BCG vaccine, if not administered properly adhering to the 8 rights of CDC before administering the vaccine, these children will not develop “Immunogenic scar”. More than 75% of births are taking place in private birthing facilities in Dakshinakannada and the neighboring district Udupi. As of now India has the dubious distinction of having highest number of Tuberculosis cases: ~27% of the world and ~35% of TB deaths. BCG vaccination is the oldest and the cheapest public health intervention but needs to be administered properly – one of the two areas of TB prevention. Now the district / state and the country are well galvanized, ready to receive an appropriate dent in the programme. Private Service providers too are keen to participate actively, proactively with proper direction and channelization by the public sector. Hence we wish to share the success story with global viewers. With best wishes Holla n KVG team EDIT: The hypothetical example had projection up to state level. On suggestion and request, I have projected it to the country level (n=26 million). The attachment has been replaced with relevant editing. 

Upcoming webinar on 5 Dec 2019: Five proven strategies to improve immunization data use

Join us for a webinar: Five proven strategies to improve immunization data use (Findings from the Immunization Data: Evidence for Action Review) Date: Thursday, December 5, 2019 3:00 pm
Europe Time (Paris, GMT+01:00) The use of high-quality data is widely understood in the global health community to be a cornerstone of well-functioning health systems. However, despite continuous growth in the amount of health data available, the actual use of data in immunization program decision-making remains a challenge. Part of the challenge has been a limited understanding of what tools and approaches actually are effective in increasing the use of immunization data to support improvements in vaccine delivery and access. The Immunization Data: Evidence for Action (IDEA) Review was undertaken to identify the existing evidence on what works to improve the use of immunization data, and to synthesize that evidence into actionable steps that implementers, policymakers and funders can take to design better data use interventions.

During this webinar, the presenters from PATH will share the methodology used to identify and review 549 pieces of evidence and five proven strategies to improve data use that were uncovered. They also will discuss the evidence gap map that was developed and how the global immunization community can work together to increase the quality of evidence available on best practices for data use to help further the work started by the IDEA team.


Discussion panelists

Laurie Werner- Director of Program, Center of Digital and Data Excellence, PATH
Allison Osterman- Program Officer, Health Systems Innovation and Delivery, PATH

Save the date and please join us! Link to register: https://who-meeting.webex.com/who-meeting/onstage/g.php?MTID=ec0039a66d95132ed3f30c6988ade4314

Next conference

Does anyone know when the next conference will be and where? Thanks

EuVac Baby Award Celebration 14 Nov 2019

Dear viewers of TechNet Greetings from the KVG team and we wish to share the attached with photos regarding celebration of 2nd EuVac Baby Award Ceremony organized in our college on 14th Nov 2019 – the Children’s’ day and also to complement world immunization day. This year KVG team decided to felicitate the parents throughout the year as soon as the baby graduates “EuVaccinee” in the vaccination clinic. All RI lovers, private stakeholders, NGOs IAP / IMA / Rotary can proactively join hands for jubilation. Happy reading Holla n Team

2019 Pneumonia & Diarrhea Progress Report Card

The 2019 Pneumonia & Diarrhea Progress Report Card—an annual report developed by the International Vaccine Access Center (IVAC) in the Department of International Health at the Johns Hopkins Bloomberg School of Public Health—is now live. This year’s report card finds health systems are falling short of ensuring the world’s most vulnerable children have access to prevention and treatment services in the 23 countries that together account for 75% of global pneumonia and diarrhea deaths in children under 5. It describes progress in fighting pneumonia and diarrhea in countries with the highest absolute number of deaths and, for the first time, in countries with the highest rates of deaths from these illnesses. While the report card identifies progress—increases in immunization coverage—it also describes a near-universal failure to meet GAPPD targets across 23 countries with the greatest burden of disease. About IVAC The International Vaccine Access Center (IVAC) applies rigorous science to build knowledge and support for the value of vaccines. Based in the Department of International Health at the Johns Hopkins Bloomberg School of Public Health, with a team of over 40 physicians and professors, economists and epidemiologists, researchers and advocates, IVAC provides global technical leadership on over 15 vaccine-preventable diseases. IVAC’s approach utilizes leading-edge science, clear communication, productive partnership, and capacity building. By generating, synthesizing, and using evidence to inform decision-making and action, we accelerate equitable and sustainable access to vaccines globally.

VVM

Great achievement for the VVM. Bravo Umit

Is it time to explore a different way of looking at immunization coverage and system strength?

A recent article in Science authored by Michael Mina and colleagues concludes that measles infection reduces antibodies that provide protection against infections thereby reducing the benefits of prior vaccination (https://science.sciencemag.org/content/366/6465/599). Measles vaccination acts as an essential complement to other vaccines; hence, defining system strength by DTP3 or MCV1 coverage appears inadequate. Because coverage can also be seen as a probability, it is possible to multiply DTP3 and MCV1 coverage to obtain the probability that an infant has received both. With this joint coverage approach, there is still a reassuringly high number of countries where coverage exceeds 90%. However, not surprisingly, there are about twice as many countries with coverage less than 70% using the joint methodology than through the use of either DTP3 or MCV1. The use of a joint coverage approach may be better at identifying weaknesses and fragility in immunization systems.

Webinar Invitation: Integrating Drones into Immunization Supply Chains

Hello TechNet-21 members, 

The UAV for Payload Delivery Working Group (UPDWG) invite you to attend a special, one and a half hour webinar, jointly hosted by UPDWG and TechNet-21 on integrating drones into immunization supply chains.  Webinar: Integrating Drones into Immunization Supply Chains When: November 7, 2019 | 10-11:30 AM EST Description: Resilient, high-performing immunization supply chains (iSCs) are the basis for strong primary health care systems and the foundation for reaching global immunization coverage and equity targets. Yet efficient and reliable transportation for immunization products still remains a challenge in many low and middle-income countries. New technologies, such as drones, have the potential to revolutionize traditional modes of transportation but how do you know if these technologies are the right fit for your context?
In this webinar, UPDWG and TechNet-21 will explore when integrating drones (or UAVs) into existing iSCs is feasible and how you can operationalize drones in existing immunization programs. UPDWG Members from UNICEF and VillageReach will share their experiences from Vanuatu and the Democratic Republic of Congo (DRC), in integrating drones transportation into the routine immunization supply chain.  After the presentations, we will open the floor for a panel discussion with VillageReach DRC and former UNICEF Vanuatu staff.  Hosts: 
Olivier Defawe - UPDWG
Daniel Brigden - TechNet-21, The Technical Network for Strengthening Immunization Services

Case Study Presenters: 
Jaime Archundia - UAS Global Lead, UNICEF
Luciana Maxim - Sr. Manager, Research Evidence and Learning, VillageReach

Discussion Panelists: 
Ridwan Gustiana - Health Specialist, Immunization UNICEF (formerly UNICEF Vanuatu) 
Archimede Makaya - Equateur Provincial Coordinator, VillageReach DRC
Dieudonne Nsekela - Program Officer, New Technologies, VillageReach DRC
Christian Vazquez - Civil Engineer, Transportation Engineering (formerly UNICEF Vanuatu)  Registration: https://zoom.us/meeting/register/c638a89ac5516f0d8c34be5db4a05ad8   I hope you can join us for this exciting webinar!    Best,  Gabriella Ailstock Coordinator, UAV for Payload Delivery Working Group (UPDWG) info@UPDWG.org | UPDWG.org

Webinar on PQS cold chain equipment area on TechNet: 17 October 2019

Do you work with WHO PQS-prequalified cold chain equipment – refrigerators and freezers, cold boxes and vaccine carriers, coolant packs, and temperature monitoring devices? If so, you may be interested in the new Cold Chain Equipment (CCE) area of TechNet-21.org, which includes detailed information on all WHO PQS-prequalified products, including installation and maintenance guides, training resources, brochures, videos, photos, as well as product feedback from TechNet members. Next month, TechNet will host a webinar on the new CCE area. We will explain how to use the new area, as well as how PQS manufacturers can manage the information and resources provided for their products. An update on the new WHO PQS website will also be provided. The webinar will take place at 4pm CEST on Thursday, 17 October and will be moderated by Alex Pascutto, TechNet Community Manager. The following experts will also be on the panel: Dan Brigden (WHO EPI) Isaac Gobina (WHO PQS) Matt Morio (PATH) Gemma Huckerby (consultant) Others TBC The link to the webinar will be provided one week before the date. Save the date and please join us!   About the CCE area Every PQS-prequalified CCE product has been given its own page. Each page includes detailed information on that product, including: Product data from the WHO PQS CCE website Resources for the product shared by TechNet members, including technical guidance from WHO, UNICEF, and other partners, installation and maintenance guides, training materials, and manufacturer brochures Videos on the product Feedback from TechNet members on the product PQS manufacturers with a TechNet account can manage some of the information displayed on their product pages, for example by updating the product description, as well as adding product photos and videos. Note: the CCE area features technical information available on the WHO PQS Catalogue website. Please refer to this website for official WHO guidance and the latest information on PQS products.

WHO/UNICEF estimates of national vaccination coverage (WUENIC) study: 'Have your say'

Dear Members of TechNet-21,   Do national coverage estimates affect your work? Do you use estimates to make decisions? Are you interested in contributing to their improvement? If you have answered yes to any of these questions we would love to hear what you have to say about this important indicator.   Supported by WHO and UNICEF, Swiss TPH are conducting a study to explore: 1. the use and usefulness of estimates for decision making, and 2. methodological approaches to improve estimates of national immunization coverage.   Please find attached the WHO/UNICEF WUENIC project introduction letter which includes further details and the link to the online survey (15 minutes). You can also access the survey directly here: https://forms.gle/9dUMZb1zABRdbkmb8   Many thanks for your interest and support, Caitlin & the Swiss TPH study team  

What is the role and use of serosurveys in immunization to deal with hard situation like continued WPV circulation detected in through environmental surveillance in district Lahore Punjab, Pakistan?

Pakistan is among 2 last countries with Afghanistan that are struggling to eradicate polio from the country. Despite of repeated SIA's (more than 100 rounds) and having good LQAS results showing high coverage, still WPV is being detected (Human Polio cases as well as positive Environmental samples). So, would there be a role and use of serosurveys in this regard? Please look at the attached file from Punjab Pakistan where details can be appreciated in the weekly reports.

Replication of CMEWS for acceleration

Dear viewers We wish to share the attached with End TB stakeholders for dissemination and needful. India is committed, eradicated polio and got the certificate in March 2014. In 2018, declared to End TB [Elimination] by 2025, aims to achieve prevalence rate of ≤65, incidence of ≤44 and mortality of ≤3 per lakh population per year and zero catastrophic cost which looks too ambitious. India also declared to screen below 18 year population both for TB and Leprosy and to put on treatment if required. This will help in minimizing the population infection [reservoir of infection]. In this regard vaccinating with live attenuated vaccine in potent condition without any programmatic error early as possible to the newborns for obtaining “immunogenic scar”, administering tuberculin without any programmatic error for early detection of TB infection, early diagnosis and prompt treatment of all TB cases are mandatory. KVG team proactively and opportunistically discovered several programmatic errors in the administration of tuberculin, shared with stake holders, demosite was established at KVG Medical College, with the support from the government and active participation by the medical colleges in Karnataka rapid replication is happening through CMEW on TST. This is expected to totally eliminate long standing universal operational gaps in administering tuberculin. The attached is the highlights of CMEW held at KVGMCH and KIMS Mangaluru on 15th and 16th October respectively for global sharing. with best wishes Holla n team

Webinar: Analysis of the Situation of Digital Health in Central America: The experience of Central American Health Informatics Network

Webinar organized by Asia eHealth Information Network (AeHIN) in which we shall analyze the current situation of Digital Health in Central America through the accumulated experience of Central American Health Informatics Network (RECAINSA) Speakers: - Joseline Carías Galeano, Coordinator of Communication and Digital Strategy of RECAINSA - Daniel Roberto Otzoy Garcia, Coordinator of RECAINSA  Date: October, 22th 2019  Time: 7 AM Central America Time / 9 AM Washington D.C./ 3 PM Geneva / 9 PM Philippines Time. Register: http://bit.ly/2MP6MHl We thank you for your participation and for sharing with your contacts. Best regards Daniel

Immunization coverage surveys

Reports of Latest surveys in Latina America are available here?

HLN Releases Version 1.21.1 of its Award Winning Open Source Immunization Forecaster

On October 15, 2019, HLN released a new version (v1.21.1) of the Immunization Calculation Engine (ICE). ICE is a state-of-the-art open-source software system that provides clinical decision support for immunizations for use in Immunization Information Systems (IIS), Electronic Health Record (EHR) and Personal Health Record (PHR) Systems. This version includes important updates to the DTP Vaccine Group including: Updated HPV rules as per the June 2019 ACIP approved recommendations, including a harmonized recommendation for catch-up vaccination for males and females through age 26 years and recommendation based on shared clinical decision making for individuals aged 27 through 45 years who are not adequately vaccinated. Slight change to the way the dose number included in the vMR output is determined. The full software release is available for download at https://cdsframework.atlassian.net/wiki/display/ICE/Downloads. A revised ICE Implementation Guide is also available. See the feature article about ICE in Open Health News.

New post in RECAINSA's blog

Dear colleagues We have a new post in Central American Health Informatics Network (RECAINSA)!! Abstract: The registration of information about family visit done by primary care level personnel, was carried out for almost 40 years, in the Family Factsheets in cardboard, this resulted in an obsolete and inefficient method in data analysis processes, carrying out statistical balances, timely references, because the information was not encoded, nor available. The aforementioned posed innovative challenge of using information technologies as an enhancer to facilitate education, health promotion and disease prevention, which is why Mobile Family Record (Mobile SIFF) was developed as a work tool that It allows the ATAP (Primary care technicians), to collect the information that is generated in the home visits in an agile, practical and safe way, and also keep track of the activities carried out in the home visit, consultation of promotional material, capture and update of the data of the family record, synchronization with the Integrated Family Record System (SIFF in Spanish) and Integrated Security Module (MISE) currently used by the Social Security Fund of Costa Rica. This intention provided a substantial boost in the issue of eHealth, specifically in mHealth (or health by mobile devices) this because not only a tool is provided to facilitate the processes of providing services digitally. It allows it to be ubiquitous with associated mobility, where information can be accessed from anywhere and from anyone. Complete article (Spanish*): http://bit.ly/2VtSBLO * You can use the translation option located in upper right side of our Web Site, available in English, French and Portuguese. Thanks for reading, feedback and sharing. Best regards Daniel

Development of new technology

I am a refrigeration technician working in Kenya Bomet county under the ministry of heath. I am dealing with vaccine fridges for immunization. I will be in touch with you in new development of cce.

Immunization Supply Chain Action Plan

Dear TechNet Members, Bhutan is going to develop Immunization Supply Chain Action Plan as a recommendation of the Regional ISC review meeting 2017. Appreciate if members could kindly share the sample of similar action plan for us to have an idea.  Thanks, Chandralal 

CMEW for sensitizing on TST at JJMMC - Davangere, Karnataka, India

Dear viewers  Last month when the above workshop was conducted at St John Medical College Bengaluru, replication for acceleration was anticipated. KVG team wishes to share the following in brief. Exactly a month back on 04th Sep 2019, St John Medical College Bengaluru, Karnataka, India invited KVG team to conduct CMEW to sensitize service providers [Testers] and specialists who prescribe and read the test for diagnostic purpose in their college. A feedback and a feed forward were shared with SJMC and the higher-ups including global partners of End TB programme through techNet-21. As committed by Dr Balu PS, STF Chair of RNTCP for Karnataka state, Professor and HOD, department of Community Medicine, JJMMC Davangere organized similar programme in their college on 4th Oct 2019; sharing the highlights as continuation of extended success of the vision in mission mode. About the CMEW held at JJMMC Davangere: ~ 2hr CMEW was held on 04th October afternoon. 45 participants from all the key departments attended the programme. Dr Balu PS, STF chair Karnataka, Professor and HOD department of community medicine JJMMC moderated the CMEW. He expressed and wished: “it’s a useful training, do request RNTCP nodal officers to have in u r college;….we also take this opportunity to felicitate holla sir for his contribution towards polio eradication efforts and strengthening Routine Immunization in state of Karnataka”. He thanked Dr Murugesh SB, the Principal for all his support. Dr Mugana Gowda Patil – professor and head of the department of pediatrics and Dr Mohan Maruliah – the Director Bapuji child health institute for participating in the workshop as chief invitees and chair persons. On the spot they committed to administer TST as per CDC / GoI / RNTCP guidelines to support “End TB” timely. Extension of Vision and Mission: Similar vision and mission in administering Newborn BCG vaccine with no programmatic errors under Routine Immunization programme will help the newborns to develop “IMMUNOGENIC BCG SCAR”. According to recent studies, newborn BCG vaccination is ~80% effective in protecting the children from the catastrophic impact of TB and can drastically reduce Mtb population infection (the reservoir of infection). Programmatic errors are bound to occur as >70% birthing are taking place in private birthing institutions and the vaccination commonly yields “ULCEROGENIC SCAR” – soft, shallow, and hyper pigmented which we routinely see in the vaccination clinic which can delay the reduction of “population infection”, retarding the achievement of national and global goals.  Way forward: Conducting similar CMEW in the remaining Medical Colleges of Karnataka followed by hands on intensive training of testers in the follow up supportive supervision visits. In the near future reporting format will be edited to capture core data on TST.  Acknowledgement: We thank all the supporters of “End TB” programme. Same we attched with a few photos. with best wishes and regards to the viewers Holla n Team    

Discussion: The IDEAL-Vietnam project would like global feedback and collaboration on the topic of, “Partnering with Mobile Network Operators for electronic immunization registry application”, after the release of the project’s first case study.

The PATH, Introducing Digital immunization information systems- Exchange and Learning (IDEAL) project, funded by the Bill & Melinda Gates Foundation is excited to release the first lessons learned on transitioning from a paper-based immunization registry to an entirely digital system. The case study reflects necessary partnerships in the development and scale-up of current electronic immunization registry (EIR) in Vietnam, the National Immunization Information System (NIIS). The study describes the benefits and challenges of partnerships between the Ministry of Health, PATH and Mobile Network Operator (Viettel). Both local governments, partnering NGOs and Mobile Network Operators play a vital role in the application of a software-based immunization registry, but as Vietnam’s story demonstrates there is both critical advanced planning and necessary steps to ensure these partnerships are as strong and sustainable as possible, maximizing both resources and time to increase health benefits. The study discusses the development of partnerships that enabled the successful scale-up of Vietnam’s NIIS from a pilot project to a nation-wide application. The World Health Organizations, “A practical guide for engaging with mobile network operators in Health for reproductive, maternal, newborn and child health” was used as a comparative guide in the case study, to relate Vietnam’s experience to existing EIR global resources. The case study highlights the benefits of key partnerships in EIR implementation and drivers for cultivating partnerships from both MNO and MOH perspectives. The report also demonstrates the hurdles that Vietnam experienced, demonstrating when possible, how Vietnam was able to overcome the challenges as the country continues to transition to an entirely digital immunization registry. The first lesson learned case study also serves as a gateway to introduce IDEAL’s new homepage on TechNet-21, where you can find all IDEAL- project reports, announcements and materials in English and Vietnamese. Over the course of the next two years IDEAL-project will explore more lessons learned from Vietnam in the process of moving to completely digital, each zoning-in on an important aspect of the electronic immunization registry process.   IDEAL-Vietnam project would like your feedback on the first case study and first topic of our lessons learned library, “Partnering with Mobile Network Operators”: 1.) What has been some of your countries/organization’s key challenges in the identification, formation, or maintenance of a partnership with a MNO?   2.) What lessons learned or take-away message did you find most valuable for our case study?   3.) What are some lessons learned or take-away messages you think are important to share from your country/organizations experience/partnerships?   4.) What are some other global guidance documents your country/organization have used to determine best practice for forming necessary partnerships for the EIR application?   5.) What aspects from the Vietnam perspective can your own country/organization relate to in regard to the partnerships formed for EIR application? What aspects are less relatable?   6.) If the IDEAL-project could expand/revise this case study in the future what areas would be most helpful to detail further?  

Innovate to sustain; Replicate to Accelerate: MR Elimination

Dear viewrs of techNet community We wish to share the attached wherein a planning unit lead by AYUSH Lady Medical Officer has attained and sustained >95% FIC below one year and DPT 1st booster with OPV and MCV/MRCV. We feel proud to share this as it is attached to our Medical College.  Quote-2012: “With near eradication of poliomyelitis, global immunization commitments have to be in clear focus. Chasing measles outbreaks is costly to families and health systems. It is time to move faster to fill population immunity gaps”. Department of Health and Family Welfare services Dakshinakannada district in collaboration with partner organization (WHO) organized district level workshop on Measles elimination and Rubella control – the need of the year / month / week / day / hour.  Venue – IMA Bhavan, Mangaluru. District Health & FW officer Dr Ramakrishna Rao along with team of resource persons lead by SMO Dr Sathishchandra formally inaugurated the programme. He emphasized that Medical Officers have to identify the gaps in vaccination and close it timely. Team of resource persons spoke on the following topics moderated by SMO who interactively elaborated on strategies of elimination, case based surveillance, outbreak response using “Mentimeter”, case studies and “station approach” for active participatory learning. 1.    Measles and Rubella (MR) Epidemiology 2.    MR elimination strategy 3.    Progress on MR case based surveillance 4.    Modified MR case based surveillance 5. Revised outbreak response 6. HRA prioritization 7. Monitoring Indicators and data analysis 8. Case studies & Station approach Attaining and sustaining ≥95% MRCV two doses is the first of the 5 strategies. Dr Holla shared the following successful models operating in the field since Jan 2013 for attaining the same. Way back in Dec 2012, “Xmas Gift” was posted in the techNet-21 assuring >90% backlog clearance of MCV2 from 6% on 10th Jan 2013 – in just 2 weeks [Peraje Template]. The dramatic and unprecedented result of Peraje Sub-Centre was presented in the Academic Society Meeting in the Medical College on 30th Jan 2013 and ambitiously in the District Task Force [DTF] meeting at Dakshinakannada for replication in all the PHCs of the district. In just 3 months [Jan/Feb/Mar 2013] entire PHC Sampaje reached >95% of Full Immunization of below one year and complete immunization before 2nd year which included 2 doses of Measles. [Immunogram article published]. Measles and Rubella was introduced since Feb 2017. The attached 2 pager with photo will be shared with the viewers for any additional inputs. Way forward: District task force [DTF] to empathetically appreciate the success of PHC Kollamogru and replicate in all the planning units for acceleration. On authorization, KVG team is proactive in accelerating the coverage of MRCV two doses in all the remaining planning units of the district.  Acknowledgement: We thank the organizers for inviting faculty from departments of pediatrics and community medicine of private medical colleges and the management for deputing KVG team. With best wishes Dr Holla n Team                


Il n'existe aucune discussion disponible ici
  1. Discussions: 2782
  2. Dernier membre: Loic Cohen
Membres en ligne